Update on the management of febrile neutropenia in hematologic patients.

Update on the management of febrile neutropenia in hematologic patients.
Rev Esp Quimioter. 2019 Sep;32 Suppl 2:55-58
Authors: Escrihuela-Vidal F, Laporte J, Albasanz-Puig A, Gudiol C
Abstract
Febrile neutropenia is a common complication in patients with hematologic malignancies receiving chemotherapy, and is associated with high morbidity and mortality. Infections caused by multidrug-resistant bacteria represent a therapeutic challenge in this high-risk patient population, since inadequate initial empirical antibiotic treatment can seriously compromise prognosis. Besides, reducing antimicrobial exposure is a cornerstone in the fight against resistance.
PMID: 31475812 [PubMed - in process]

Source: Revista Espanola de Quimioterapia - August 31, 2019 Category: Drugs & Pharmacology Authors: Escrihuela-Vidal F, Laporte J, Albasanz-Puig A, Gudiol C Tags: Rev Esp Quimioter Source Type: research